188 results on '"Franzè E"'
Search Results
2. OC.13.5: PROTECTIVE EFFECTS OF ADENOSINE DEAMINASE RNA SPECIFIC 1 IN INFLAMMATORY BOWEL DISEASE
3. mTOR sustains inflammatory response in celiac disease
4. An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa
5. T.07.3 HEPCIDIN SUSTAINS COLORECTAL CANCER CELL SURVIVAL
6. PC.01.3 BROMODOMAIN-CONTAINING PROTEIN 4 (BRD4) ENHANCES INTERLEUKIN-34 EXPRESSION IN INFLAMED GUT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
7. Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis
8. OC.07.4 RAFOXANIDE INDUCES IMMUNOGENIC DEATH OF COLORECTAL CANCER CELLS
9. OC.06.5 GATA6 DEFICIENCY LEADS TO EPITHELIAL BARRIER DYSFUNCTION AND ENHANCES SUSCEPTIBILITY TO GUT INFLAMMATION
10. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
11. Follistatin-like protein 1 sustains colon cancer cell growth and survival
12. OC.16.3 THE FRAGILE X MENTAL RETARDATION PROTEIN REGULATES RIP1K AND COLORECTAL CANCER RESISTANCE TO NECROPTOSIS
13. OC.11.3 THE DEUBIQUITINASE OTUD5 ENHANCES INFLAMMATORY CYTOKINE PRODUCTION IN THE GUT OF INFLAMMATORY BOWEL DISEASE PATIENTS
14. OC.11.2 INTERLEUKIN-34 STIMULATES GUT FIBROBLASTS TO PRODUCE COLLAGEN SYNTHESIS
15. OC.16.2 PROGRANULIN SUSTAINS STAT3 HYPER-ACTIVATION AND ONCOGENIC FUNCTION IN COLORECTAL CANCER CELLS
16. OC.13.3 SMAD7 KNOCKDOWN REDUCES THE ACTIVATION OF STAT3 IN COLORECTAL CANCER
17. OC.13.1 SMAD7 REGULATES IMMUNOGENIC DEATH PATHWAY IN COLORECTAL CANCER CELLS
18. OC.03.1 REGULATION OF COLON CARCINOGENESIS BY THE ANTI-HELMINTH AGENT RAFOXANIDE
19. OC.10.1 RECIPROCAL REGULATION BETWEEN SMAD7 AND SIRT1 IN THE GUT
20. OC.01.4: Interleukin-34 Sustains Pro-Tumorigenic Signals in Colon Cancer Tissue
21. OC.14.3: PAD4 and Neutrophil Extracellular Traps are Increased in the Inflamed Colon Mucosa of Patients with Ulcerative Colitis
22. P.05.1: Interferon Regulatory Factor 5 Expressing Cells Infiltrate Lamina Propria of IBD Patients and Produce Inflammatory Cytokines
23. OC.01.2: Rorgamma-T-Expressing Regulatory T Cells Sustain Colorectal Cancer Growth Through a Foxo3-Dependent Suppression of Dendritic Cell-Derived IL-6 Production
24. OC.09.8 INTERLEUKIN-34 INDUCES CC-CHEMOKINE LIGAND 20 IN GUT EPITHELIAL CELLS
25. Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut
26. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
27. PC.01.2 SMAD7 SUSTAINS COLON CANCER CELL GROWTH BY MODULATING PP1 AND EIF2-ALPHA TO REGULATE CDC25A
28. OC.03.1 SMAD7 EXPRESSION AND REGULATION BY SIRT1 IN INFLAMMATORY BOWEL DISEASES
29. P.06.6 PLASMA CELLS IN THE MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE PRODUCE GRANZYME B AND POSSESS CYTOTOXIC ACTIVITIES
30. OC.05.2 TH17-RELATED CYTOKINES AND EXCESSIVE ACTIVATION OF STAT3 SUSTAIN COLORECTAL CANCER CELL GROWTH
31. P.06.5 A FUNCTIONAL ROLE FOR IL-34 IN SUSTAINING INFLAMMATORY PATHWAYS IN IBD
32. A functional role for Smad7 in sustaining colon cancer cell growth and survival
33. OC.04.3 EXPRESSION OF TBET AND RORGAMMA-T IN REGULATORY T CELLS INFLUENCE THE INCIDENCE AND SIZE OF TUMOR MASSES IN A CAC MODEL
34. P.05.2 DIMINISHED EXPRESSION OF SCAVENGER RECEPTORS ASSOCIATES WITH ACCUMULATION OF APOPTOTIC BODIES IN CELIAC DISEASE MUCOSA
35. P.18.8 IL-25 PREVENTS AND CURES FULMINANT HEPATITIS THROUGH A MYELOID-DERIVED SUPPRESSOR CELL-DEPENDENT MECHANISM
36. OC.10.5 IN VITRO AND IN VIVO KNOCK-DOWN OF SMAD7 INHIBITS GROWTH AND PROMOTES APOPTOSIS OF COLON CANCER CELLS
37. OC.12.6 CHARACTERIZATION OF INFLAMMATORY CYTOKINE RESPONSE IN HUMAN SPORADIC COLORECTAL CANCER
38. P.03.6 CD163-EXPRESSING MACROPHAGES WITH INFLAMMATORY PROPERTIES INFILTRATE HEAVILY THE GUT MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
39. IL-15 positively regulates IL-21 production in celiac disease mucosa
40. P.05.11 HIGH EXPRESSION OF THE “A DISINTEGRIN AND METALLOPROTEASE” 19 (ADAM19), A SHEDDASE FOR TNF-α IN THE MUCOSA OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
41. OC.08.6 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A DERIVATIVE OF MESALAMINE, INHIBITS COLON CANCER CELL GROWTH THROUGH CYCLOOXYGENASE-2-DEPENDENT AND -INDEPENDENT MECHANISMS
42. OC.03.2 DEFECTIVE EXPRESSION OF THE ANTI-INFLAMMATORY SIRT1 IN INFLAMMATORY BOWEL DISEASES
43. OC.06.2: ROLE OF INTERLEUKIN-21 IN THE GROWTH OF COLITIS-ASSOCIATED COLON CANCER
44. Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut
45. P.1.101: LACTOBACILLI CASEI (LC) REDUCE TRYPSIN EXPRESSION IN INTESTINAL CELLS THEREBY LEADING TO INACTIVATION OF PAR2 AND UP-REGULATION OF ZO-1
46. P.1.33: 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE SENSITIZES COLON CANCER (CC) CELLS TO TRAIL THROUGH MODULATION OF DEATH RECEPTOR (DR)5 AND SURVIVIN
47. P.1.27: THE REGULATORY CD163-POSITIVE MACROPHAGES INFILTRATE MASSIVELY THE INFLAMED GUT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASES
48. P.64 INTERLEUKIN-25 PRODUCTION IS DIFFERENTLY REGULATED BY TNF-α AND TGF-β1 IN THE HUMAN GUT
49. P.103 2-METHOXY-5-AMINO-N-HYDROXYBENZAMIDE, A NOVEL DERIVATIVE OF 5-AMINOSALICYLIC ACID, INDUCES DR4 AND DR5 AND ENHANCES TRAIL-INDUCED APOPTOSIS IN COLON CANCER (CC) CELLS
50. ARYL HYDROCARBON RECEPTOR SIGNALLING DOWN REGULATES TH1 IMMUNO-RESPONSE IN CROHN'S DISEASE GUT MUCOSA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.